Haemonetics Corp. (MA) (HAE)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Christopher A. Simon
Employees:
2,820
400 WOOD RD, BRAINTREE, MA 02184
7818487100

Haemonetics Corporation provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software. It also provides automated blood component and manual whole blood collection systems.

Data derived from most recent annual or quarterly report
Market Cap 4.354 Billion Shares Outstanding51.11 Million Avg 30-day Volume 474.189 Thousand
P/E Ratio44.3576 Dividend Yield0.0 EPS1.27
Price to Revenue3.522 Debt to Equity1.1217 EBITDA210.235 Million
Price to Book Value5.2357 Operating Margin12.2125 Enterprise Value4.393 Billion
Current Ratio2.73 EPS Growth1.767 Quick Ratio1.574
1 Yr BETA 0.8345 52-week High/Low 91.39 / 43.5 Profit Margin7.94
Operating Cash Flow Growth136.7449 Altman Z-Score3.2425 Free Cash Flow to Firm 81.892 Million
Earnings Report2023-02-07
View SEC Filings from HAE instead.

View recent insider trading info

Funds Holding HAE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding HAE

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-11-07:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-19:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-08-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-08:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-08-01:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 1.01: Entry into a Material Definitive Agreement
    Item 1.02: Termination of a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-16:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-05-25:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-05-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-21:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-15:
    Item 7.01: Regulation FD Disclosure
  • Prospectus

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    2.4 Thousand total shares from 1 transactions

    Exercise Derivative Conversion (M)

    2.4 Thousand total shares from 1 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    LLORENS JOSEP EVP, GLOBAL MANUFACTURING

    • Officer
    24,407 2023-01-23 4

    SIMON, CHRISTOPHER PRESIDENT & CEO

    • Officer
    • Director
    205,124 2022-11-11 4

    GALVIN ROY PRESIDENT, GLOBAL PLASMA & BC

    • Officer
    7,645 2022-11-01 2

    STRONG STEWART W PRESIDENT, GLOBAL HOSPITAL

    • Officer
    15,681 2022-10-24 3

    BASIL MICHELLE L EVP AND GENERAL COUNSEL

    • Officer
    32,455 2022-10-24 6

    MAUNSELL FARRIS MARYANNE VP, CHIEF ACCOUNTING OFFICER

    • Officer
    0 2022-10-17 1

    MILLER LAURIE A. SVP, HUMAN RESOURCES

    • Officer
    12,697 2022-09-19 6

    KROLL MARK W

    • Director
    16,231 2022-08-15 2

    ABERNATHY ROBERT E

    • Director
    17,855 2022-08-05 1

    COYLE MICHAEL J

    • Director
    8,268 2022-08-05 1

    BURZIK CATHERINE M

    • Director
    19,545 2022-08-05 1

    ZANE ELLEN M

    • Director
    12,247 2022-08-05 1

    DOCKENDORFF CHARLES J

    • Director
    28,130 2022-08-05 1

    POMEROY CLAIRE

    • Director
    9,746 2022-08-05 1

    JOHNSON LLOYD EMERSON

    • Director
    5,807 2022-08-05 1

    GOLDSTEIN DAN VP, CORPORATE CONTROLLER

    • Officer
    4,447 2022-06-13 4

    LINGAMNENI ANILA EVP, CHIEF TECHNOLOGY OFFICER

    • Officer
    17,322 2022-05-19 3

    DARECCA JAMES EVP, CHIEF FINANCIAL OFFICER

    • Officer
    21,839 2022-05-16 3

    BURKE WILLIAM P. MR. EVP, CHIEF FINANCIAL OFFICER

    • Officer
    30,291 2021-08-23 0

    NIKEL CHAD M. PRESIDENT, GLOBAL PLASMA & BC

    • Officer
    17,336 2021-08-06 0

    SCANLAN JACQUELINE SVP, GLOBAL HUMAN RESOURCES

    • Officer
    4,216 2021-06-07 0

    MEELIA RICHARD J

    • Director
    32,050 2021-02-04 0

    GELBMAN RONALD G

    • Director
    48,384 2019-11-11 0

    BOLORFOROSH SAID EVP, CHIEF TECHNOLOGY OFFICER

    • Officer
    1,977 2019-11-11 0

    GRANADILLO PEDRO P

    • Director
    15,335 2018-11-08 0

    RYDING NEIL MR. EVP, GLOBAL MANUFACTURING

    • Officer
    15,226 2018-06-07 0

    FOOTE SUSAN BARTLETT

    • Director
    20,740 2017-11-10 0

    MERRIMAN RONALD

    • Director
    17,807 2017-05-22 0

    JESSE SANDRA EVP AND CHIEF LEGAL OFFICER

    • Officer
    48,166 2016-10-25 0

    SELMAN BYRON PRESIDENT, GLOBAL MARKETS

    • Officer
    23,318 2016-10-25 0

    FUSCO DAVID EVP, GLOBAL HUMAN RESOURCES

    • Officer
    16,867 2016-10-25 0

    LINDOP CHRISTOPHER J CFO & EVP BUSINESS DEVELOPMENT

    • Officer
    56,743 2016-01-13 0

    HANLON SUSAN M VP FINANCE

    • Officer
    20,464 2015-10-26 0

    WHITE JONATHAN CHIEF SCIENCE AND TECHNOLOGY

    • Officer
    30,507 2015-10-26 0

    BURNS BRIAN R EVP, GLOBAL QA/RA

    • Officer
    16,235 2015-10-23 0

    DAVIES KENT J CHIEF OPERATING OFFICER

    • Officer
    16,891 2015-10-23 0

    CONCANNON BRIAN PRESIDENT & CEO

    • Officer
    • Director
    186,454 2015-09-15 0

    ALLEN PETER M PRESIDENT, GLOBAL PLASMA

    • Officer
    34,102 2015-07-06 0

    HELSEL DAVE EVP, GLOBAL MANUFACTURING

    • Officer
    13,216 2015-04-13 0

    MCDANIEL KATHLEEN EVP GLOBAL HUMAN RESOURCES

    • Officer
    5,013 2014-08-28 0

    BEST LAWRENCE C

    • Director
    10,001 2014-06-12 0

    KELLY MICHAEL P PRESIDENT, GLOBAL MARKETS

    • Officer
    10,987 2013-11-11 0

    NIGHAN WARREN JR EVP, GLOBAL QA/RA

    • Officer
    7,618 2013-07-24 0

    BLACK PAUL

    • Director
    8,981 2013-07-24 0

    FORISH JOSEPH J VP, HUMAN RESOURCES

    • Officer
    162,747 2013-04-30 0

    GORDON MIKAEL PRESIDENT, GLOBAL MARKETS

    • Officer
    4,442 2012-05-03 0

    BRANCAZIO PHILLIP JOHN VP, GLOBAL MANUFACTURING

    • Officer
    38,572 2011-05-04 0

    LOPEZ ALICIA R VP, CORPORATE AFFAIRS

    • Officer
    10,647 2011-04-05 0

    RUXIN MICHAEL I VP GLOBAL SOFTWARE STRATEGIES

    • Officer
    • VP GLOBAL SOFTWARE STRATEGIES
    215 2010-11-04 0

    NUTTER BRAD CHAIRMAN OF THE BOARD

    • Officer
    • Director
    10,580 2010-07-29 0

    EBBELING ROBERT B VICE PRESIDENT, OPERATIONS

    • Officer
    123,405 2009-05-01 0

    PARE ANTHONY

    • VP & GEN MGR, SERVICES BUSINES
    2,523 2008-06-30 0

    BEUCLER MARK

    • VP & GMGLOBAL DISTRIB CHAN MNG
    35,602 2008-05-01 0

    SWENSON STEPHEN VP & GENERAL MGR, GLOBAL PLASM

    • Officer
    161,364 2008-05-01 0

    POPOVSKY MARK A VP, CORPORATE MEDICAL DIRECTOR

    • Officer
    76,463 2008-05-01 0

    GRANVILLE WILLIAM VP, MANUFACTURING

    • Officer
    73,366 2008-05-01 0

    HATTORI KEIKO PRESIDENT, HAEMONETICS JAPAN

    • Officer
    10,156 2008-05-01 0

    CONNEELY JAN VP & GM, ARRYX, INC.

    • Officer
    12,840 2008-05-01 0

    O'SHAUGHNESSY JAMES

    • VP, GENERAL COUNSEL
    46,246 2008-05-01 0

    SAKAI RYOJI PRESIDENT, JAPAN

    • Officer
    28,373 2007-06-14 0

    STILL WILLIAM ROCHE VP & GEN MRG, THERAPEUTICS BUS

    • Officer
    86,084 2007-05-01 0

    RYAN RONALD J VP AND CFO

    • Officer
    83,622 2006-08-10 0

    ECKERT ULRICH PRESIDENT, EUROPE & LATIN AM

    • Officer
    107,375 2006-06-20 0

    MATRICARIA RONALD A

    • Director
    37,000 2006-05-05 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    LLORENS JOSEP - Officer EVP, GLOBAL MANUFACTURING

    2023-01-25 16:28:42 -0500 2023-01-23 M 2,391 $56.57 a 19,625 direct yes -3.0944 0.0 1 -3.0944 2

    LLORENS JOSEP - Officer EVP, GLOBAL MANUFACTURING

    2023-01-25 16:28:42 -0500 2023-01-23 S 2,391 $90.00 d 17,234 direct yes -3.0944 0.0 1 -3.0944 2

    LLORENS JOSEP - Officer EVP, GLOBAL MANUFACTURING

    2023-01-25 16:28:42 -0500 2023-01-23 M 2,391 d 7,173 direct yes

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    HAEMONETICS CORP-MASS HAE 2023-01-27 22:15:03 UTC 3.9119 0.4081 1800000
    HAEMONETICS CORP-MASS HAE 2023-01-27 21:45:04 UTC 3.9119 0.4081 1800000
    HAEMONETICS CORP-MASS HAE 2023-01-27 21:15:04 UTC 3.9119 0.4081 1800000
    HAEMONETICS CORP-MASS HAE 2023-01-27 20:45:03 UTC 3.9119 0.4081 1800000
    HAEMONETICS CORP-MASS HAE 2023-01-27 20:15:04 UTC 3.9119 0.4081 1800000
    HAEMONETICS CORP-MASS HAE 2023-01-27 19:45:03 UTC 3.9119 0.4081 1800000
    HAEMONETICS CORP-MASS HAE 2023-01-27 19:15:03 UTC 3.9119 0.4081 1800000
    HAEMONETICS CORP-MASS HAE 2023-01-27 18:45:04 UTC 3.9119 0.4081 1800000
    HAEMONETICS CORP-MASS HAE 2023-01-27 18:15:03 UTC 3.9119 0.4081 1800000
    HAEMONETICS CORP-MASS HAE 2023-01-27 17:45:03 UTC 3.9119 0.4081 1800000
    HAEMONETICS CORP-MASS HAE 2023-01-27 17:15:04 UTC 3.9119 0.4081 1800000
    HAEMONETICS CORP-MASS HAE 2023-01-27 16:45:03 UTC 3.9212 0.3988 1800000
    HAEMONETICS CORP-MASS HAE 2023-01-27 16:15:03 UTC 3.9212 0.3988 1800000
    HAEMONETICS CORP-MASS HAE 2023-01-27 15:45:03 UTC 3.9212 0.3988 1900000
    HAEMONETICS CORP-MASS HAE 2023-01-27 15:15:04 UTC 3.9212 0.3988 1800000
    HAEMONETICS CORP-MASS HAE 2023-01-27 14:45:04 UTC 3.9212 0.3988 1800000
    HAEMONETICS CORP-MASS HAE 2023-01-27 14:15:03 UTC 3.9212 0.3988 1900000
    HAEMONETICS CORP-MASS HAE 2023-01-27 13:45:03 UTC 4.07 0.25 1900000
    HAEMONETICS CORP-MASS HAE 2023-01-27 13:15:03 UTC 4.07 0.25 1900000
    HAEMONETICS CORP-MASS HAE 2023-01-27 12:45:03 UTC 4.07 0.25 1900000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    AGF Investments Trust- AGFIQ U.S. Market Neutral Momentum Fund HAE -204.0 shares, $-24225.0 2020-12-31 N-PORT
    Advisors Series Trust- Pzena Long/Short Value Fund HAE -1286.0 shares, $-141048.48 2020-05-31 N-PORT
    FundVantage Trust- Gotham Master Neutral Fund HAE -23.0 shares, $-2006.75 2020-09-30 N-PORT
    Guidestone Funds- Strategic Alternatives Fund HAE -892.0 shares, $-66034.76 2022-09-30 N-PORT
    AMERICAN BEACON FUNDS- American Beacon SSI Alternative Income Fund HAE -2010.0 shares, $-148800.3 2022-09-30 N-PORT
    AQR Funds- AQR Multi-Asset Fund HAE -297.0 shares, $-21986.91 2022-09-30 N-PORT
    Morningstar Funds Trust- Morningstar Alternatives Fund HAE -2745.0 shares, $-233187.75 2022-10-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments